Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer. - Wikidata - awgldk - TriplyDB

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

http://www.wikidata.org/entity/Q36057441

about

CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting Tregalizumab - A Monoclonal Antibody to Target Regulatory T Cells Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data Trial Watch: Adoptive cell transfer for oncological indications Update on the challenges and recent advances in cancer immunotherapy The immunoregulatory role of type I and type II NKT cells in cancer and other diseases Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors Trial Watch: Peptide-based anticancer vaccines.Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate Tissue resident regulatory T cells: novel therapeutic targets for human disease.Trial watch: Peptide vaccines in cancer therapy Balance is a key for happiness.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Trial watch: Oncolytic viruses for cancer therapy Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.Following up tumor-specific regulatory T cells in cancer patients.Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy.Colorectal cancer and immunity: what we know and perspectives.Basic principles of tumor-associated regulatory T cell biology.Modulation of immunity by antiangiogenic molecules in cancer.Extracellular adenosine metabolism in immune cells in melanoma.Brain Tumor Immunotherapy: What have We Learned so Far?Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4(+) cells in vivo.Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β.Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17--a new mechanism of impaired antitumor immunity.IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients.Phosphoproteomics Reveals Regulatory T Cell-Mediated DEF6 Dephosphorylation That Affects Cytokine Expression in Human Conventional T Cells.Targeting latency-associated peptide promotes antitumor immunity.The immune system in cancer metastasis: friend or foe?Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander?Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity.Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.In Silico Adjuvant Design and Validation.Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse.Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells.Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.

P2860

Q26740520-79D04C52-BD5D-4B93-A6F8-DC8F820409E9 Q26742012-676712AA-6E61-4A59-AF01-D17A30ED7468 Q26772699-B83D03C3-BE68-482E-B981-A7CC9A5BE52A Q26781098-C585F3D8-84D2-461F-A521-05B675CA1F86 Q26785545-FD97A4B1-E82C-4338-9DDB-737E9B63861E Q27014693-75C97C46-10D7-4780-9225-A295AE99BA24 Q27027556-6D3DFD6F-A899-490E-AAC9-8F9395E61141 Q28072532-C482A731-5E64-4D8D-BF9D-01ADB70EB17D Q34483345-1CE7B315-08DF-4DB8-8666-522A4CFAC988 Q35644535-C97F16F3-E7B1-4A8E-BA62-436AFF9E05B8 Q35799377-1259EB90-0A8A-426A-8772-CF50498B7B37 Q35926395-C6AD4392-F83C-4553-86F9-C39D6A474B50 Q36085091-B6A83E98-4010-4002-BE08-25F343B2E930 Q36476100-05B96591-821A-4BBC-899C-E377D9872C92 Q36887825-2EB2A38B-D37E-483B-9720-924D26643B9D Q36887833-39BD7385-0300-4F0C-B305-3EB4EE106DFC Q37028023-F83323E5-8D6E-43DE-9CEE-144D399C5F03 Q37028767-D2F2CC60-BC2B-4A93-B918-05982D0AC1CF Q37195258-4DB44268-ED54-4864-BBBC-3CCE2C320934 Q37468057-5087F9D7-867A-4D45-9A3E-73E7A7AC442E Q37697520-29BD34EA-5B92-4BD5-A0C1-E1323400DA06 Q38045603-D333C902-CD05-428D-9224-320C0FE3718A Q38074154-9136B049-AFD4-4241-8775-FA695E9D372A Q38206399-819580DE-A9DD-433C-9DCD-524004C2A378 Q38542113-79E152A7-1667-47D1-BEA2-62845FB04BB9 Q38877137-CB0ABDF6-75F6-4108-991A-73C8CC1D6DAE Q38881545-90D650F6-1E79-44C1-9768-23B59CA781F9 Q39026688-4CFCCAA2-FA82-415D-B07C-710F359F403C Q40808689-32D6801B-93FA-431B-948F-65DC23616085 Q41997359-8A811A1D-1DB1-4097-9DCF-3DB38487D3BB Q42626385-7F87D9C2-D9AC-4F79-B713-AFBE57616753 Q42656251-F966F4B4-8844-4185-AE1C-E94608386E79 Q42702234-D9447C83-7948-4FAB-A909-34E8D6BF9371 Q42981057-2D0E8392-E12B-47AF-A690-1BF87E6B53F5 Q46909626-C718BE48-5EA5-4D45-AF43-E26C46F1DF32 Q48319209-11B58197-BAF8-4ED9-8D53-9410C4A4D6FD Q49148920-347734F6-92CE-4A4C-A825-40049696071F Q49327061-391BDA05-F0A4-4E29-97F1-A0C98A5BEF23 Q49788536-03469083-B652-4FE8-986E-FCF24CD7C8BA Q55287352-8194A7F1-46B6-452F-AA8D-0D9DC4B51B69

P2860

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

http://www.wikidata.org/entity/Q36057441

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

@ast

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

@en

type

label

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

@ast

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

@en

prefLabel

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

@ast

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

@en

P1433

Q36057441-E6C554B5-61ED-4105-ACFA-011F7C423326

P1476

Q36057441-D2588F3D-3497-43EA-9E28-535E1AFFE73F

P2093

Q36057441-03CC7287-7EA8-4961-B6E7-1B20691AFB0A

Q36057441-36615577-69D1-4B58-A4D0-C6BB5F4EBB69

Q36057441-5272600D-6438-448D-95B9-09EACD67CB65

Q36057441-5C553972-3B9F-47CB-8DE6-BC89492CE870

Q36057441-74A6D873-F405-483B-BF31-E3702E13AA96

Q36057441-7CA52EAD-4CF9-4919-8142-41E78C09031E

Q36057441-863F36F1-680A-470B-B945-0BFEBBD03BD9

Q36057441-D1F98CDA-7B24-43DC-A00D-3003646C483A

Q36057441-E9CD629D-7177-4C0A-9DD8-3B5602A3CDB5

Q36057441-EE6A45AB-34EB-4FD9-A2F9-0223DF7D3069

P2860

Q36057441-014C1A92-A3BC-442F-8A87-5E69C88722D6

Q36057441-032336AA-117C-42AB-ADB8-EE99D0FE5FE0

Q36057441-0C1C2EA0-44EF-4C80-B8B3-C8AEC85C118F

Q36057441-0C40979A-D6F4-4A89-BDAA-1FEB31D3F155

Q36057441-102FF9B2-3301-431E-B494-75A0441F0B3F

Q36057441-11269155-99CE-4F45-95A5-F2507FCD488D

Q36057441-14815D5D-F4E1-424D-8860-A872D7731863

Q36057441-14919F28-3831-44B6-BCDA-62465F3ED479

Q36057441-15F5A164-501F-42BC-94B5-9DFDDC1D2E3E

Q36057441-19DD7A68-5336-4870-8530-19C4774EE6C5

P304

Q36057441-02F9BB88-D2E9-47DC-A5A0-DA279ADC757F

P31

Q36057441-93E662D5-5CD6-46A1-A8C3-D5F4F6FC34CA

P356

Q36057441-3B697844-5313-4C32-A7B1-0343D4B60AA9

P433

Q36057441-CF4C683C-8D91-4F1A-AEF8-9F9A3D5A94DB

P478

Q36057441-C61317C2-92AB-4BF5-A92D-4558ACA63AC8

P50

Q36057441-20523F8E-48D4-40BB-B535-1803A946157C

Q36057441-22B03CE2-5779-46AF-9097-873C73034356

Q36057441-304EA4FB-2345-424C-A885-75D1581DE910

Q36057441-6690B2D2-E27E-43C3-BD1E-AC4583B97DE4

Q36057441-9DA52EFA-245E-4C34-8414-77D874C013B6

Q36057441-A43B52A5-861F-429E-94C3-6AE0C754887D

Q36057441-D6C29D53-E39C-4ACB-9287-FD9ECBFD1514

P577

Q36057441-C5CEEBFE-BE1E-4EF6-BA1D-9B37DF37971D

P5875

Q36057441-A3DF2ADA-9946-4362-BA28-A2F7A19EF25C

P698

Q36057441-C3325D6E-A982-44D9-AD83-4537A3DFD630

P932

Q36057441-C75F50C1-FBDA-4F98-AB88-AD9FA82B5BDE

P356

P1433

P1476

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

@en

P2093

Alain Carpentier

http://www.w3.org/2001/XMLSchema#string

Cecile Badoual

http://www.w3.org/2001/XMLSchema#string

Claire Banissi

http://www.w3.org/2001/XMLSchema#string

Corinne Tanchot

http://www.w3.org/2001/XMLSchema#string

Elie Marcheteau

http://www.w3.org/2001/XMLSchema#string

Federico Sandoval

http://www.w3.org/2001/XMLSchema#string

Françoise Quintin-Colonna

http://www.w3.org/2001/XMLSchema#string

Helene Pere

http://www.w3.org/2001/XMLSchema#string

Mevyn Nizard

http://www.w3.org/2001/XMLSchema#string

Nathalie Merillon

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells

Control of regulatory T cell development by the transcription factor Foxp3

IL-17 and Th17 Cells

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors

FOXP3+ regulatory T cells in the human immune system

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

How regulatory T cells work

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

P304

326-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.18852

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

Wolf Hervé Fridman

Jagadeesh Bayry

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228072414

http://www.w3.org/2001/XMLSchema#string

P698

22737608

http://www.w3.org/2001/XMLSchema#string

P932

3382865

http://www.w3.org/2001/XMLSchema#string